Price to Book Value Chart

View Price to Book Value for NXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2022. Start Trial.
Date Value
June 29, 2026 2.444
June 26, 2026 2.531
June 25, 2026 2.433
June 24, 2026 2.387
June 23, 2026 2.568
June 22, 2026 2.653
June 18, 2026 2.624
June 17, 2026 2.802
June 16, 2026 2.802
June 15, 2026 2.884
June 12, 2026 3.073
June 11, 2026 3.369
June 10, 2026 3.273
June 09, 2026 3.209
June 08, 2026 3.576
June 05, 2026 3.734
June 04, 2026 3.850
June 03, 2026 3.797
June 02, 2026 3.922
June 01, 2026 4.111
May 29, 2026 4.350
May 28, 2026 4.164
May 27, 2026 3.986
May 26, 2026 3.423
May 22, 2026 2.693
Date Value
May 21, 2026 2.845
May 20, 2026 2.389
May 19, 2026 2.289
May 18, 2026 2.314
May 15, 2026 2.442
May 14, 2026 2.424
May 13, 2026 2.427
May 12, 2026 2.442
May 11, 2026 2.425
May 08, 2026 2.513
May 07, 2026 2.453
May 06, 2026 2.481
May 05, 2026 2.567
May 04, 2026 2.712
May 01, 2026 2.712
April 30, 2026 2.534
April 29, 2026 2.474
April 28, 2026 2.639
April 27, 2026 2.888
April 24, 2026 3.037
April 23, 2026 3.074
April 22, 2026 3.351
April 21, 2026 3.112
April 20, 2026 3.324
April 17, 2026 3.304

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Accuray, Inc. 0.7439
ResMed, Inc. 4.353
Rockwell Medical, Inc. 0.6060
Microbot Medical, Inc. 1.758
Stereotaxis, Inc. 11.68

Price to Book Value Related Metrics

PS Ratio 22.02
Price 0.3374
Earnings Yield -136.9%
Market Cap 6.944M